Extended-release Guanfacine Hydrochloride in Children/Adolescents With Attention-deficit/Hyperactivity

NCT03662763 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

12

Enrollment

OTHER

Sponsor class

Conditions

Attention Deficit Disorder

Interventions

DRUG: Extended-release Guanfacine Hydrochloride (SPD503)
DRUG: Placebo oral capsule

Sponsor

Maastricht University Medical Center

Collaborators

[object Object]